Bonus Issue of Equity Shares: Metropolis Healthcare Ltd

Metropolis Healthcare Ltd has announced a Bonus Issue of Equity Shares as part of its corporate action. Trading members and investors are informed that the company has fixed the Record Date to determine shareholder eligibility for the bonus issue. The equity shares of the company will trade on an Ex-Bonus basis with effect from the date mentioned below.

Details of Corporate Action

Impact on Shareholding

Shareholders holding equity shares of Metropolis Healthcare Ltd as on the Record Date (20 March 2026) will be eligible to receive bonus shares in the 3:1 ratio. This means eligible investors will receive three additional equity shares for every one share held.

While the number of shares held by investors will increase significantly, the overall investment value generally remains proportionately unchanged, subject to market price adjustment following the bonus issue.

Allotment Information

As informed by the company in its communication dated 10 March 2026 and 12 March 2026, a total of 15,54,95,826 equity shares will be allotted on 23 March 2026 pursuant to the bonus issue.

Transactions in the equity shares will be on an Ex-Bonus basis from 20 March 2026 under Settlement No. DR-844/2025-2026.

Note

A bonus issue is a corporate action in which a company distributes additional shares to its existing shareholders free of cost by capitalizing its reserves. After the bonus issue, the share price typically adjusts downward to reflect the increased number of shares outstanding, without affecting the company’s underlying fundamentals.

Conclusion

The bonus issue by Metropolis Healthcare Ltd represents the company’s initiative to reward shareholders and enhance market participation. The 3:1 bonus ratio will substantially increase the number of shares outstanding and may potentially improve liquidity in the stock.